Applying artificial intelligence for cancer immunotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zhijie,Xu

第一单位： Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, China.

作者： Zhijie,Xu ^[1] ; Xiang,Wang ^[2] ; Shuangshuang,Zeng ^[2] ; Xinxin,Ren ^[3] ; Yuanliang,Yan ^[4] ; Zhicheng,Gong ^[4]

作者单位： Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, China. ^[1] Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China. ^[2] Center for Molecular Medicine, Xiangya Hospital, Key Laboratory of Molecular Radiation Oncology of Hunan Province, Central South University, Changsha 410008, China. ^[3] Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China.;Institute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China. ^[4]

关键词 AI, artificial intelligence Artificial intelligence CT, computed tomography CTLA-4, cytotoxic T lymphocyte-associated antigen 4 Cancer immunotherapy DL, deep learning Diagnostics ICB, immune checkpoint blockade MHC-I, major histocompatibility complex class I ML, machine learning MMR, mismatch repair MRI, magnetic resonance imaging Machine learning PD-1, programmed cell death protein 1 PD-L1, PD-1 ligand1 TNBC, triple-negative breast cancer US, ultrasonography irAEs, immune-related adverse events

DOI 10.1016/j.apsb.2021.02.007

PMID 34900525

发布时间 2024-08-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Acta pharmaceutica Sinica. B

2021年11卷11期

3393-3405页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Applying artificial intelligence for cancer immunotherapy.

Acta pharmaceutica Sinica. B

相似文献

Acta pharmaceutica Sinica. B

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Applying artificial intelligence for cancer immunotherapy.

Acta pharmaceutica Sinica. B

相似文献

Acta pharmaceutica Sinica. B

相关期刊

检索历史清除